[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 1978

Subcutaneous Heparin-Induced Thrombocytopenia

Author Affiliations

From the Department of Internal Medicine, University of Minnesota, Minneapolis.

Arch Intern Med. 1978;138(10):1489-1491. doi:10.1001/archinte.1978.03630350023009

Two patients developed severe and symptomatic thrombocytopenia which was clearly related to the every-12-hour subcutaneous administration of heparin sodium. One patient died of hemorrhage while the other patient's platelet count normalized after withdrawal of the therapy. The literature reveals 27 cases of significant thrombocytopenia associated with intravenous heparin administration. In light of the increasing use of low-dose subcutaneous heparin therapy it is important to recognize that this side effect may occur. Periodic platelet counts are recommended for these patients.

(Arch Intern Med 138:1489-1491, 1978)